- Latest week
- 24 Jul 2026
- Close
- 18.090000
- Fair value
- 16.877526
- Next-week expectancy
- Undecided 50.50%
CURE Chart Pack
VanEck Genomics and Healthcare Innovators UCITS ETF
Chart Summary
Over the latest 12 completed weeks ending 2026-07-24, CURE rose 16.24%, moving from 15.56 to 18.09. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -4.00 and has improved across the 12-week window. Market Dynamics is 1.18 on the latest week. Next-week expectancy is undecided at 50.50% based on similar historical setup states.
Key Points
- Week Ending
- 24 Jul 2026
- Latest Close
- 18.09
- 12-Week Change
- 16.24%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Undecided 50.50%
- Signal Weeks
- 0 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- -4.00
- Market Dynamics
- 1.18
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 24 Jul 2026
- Latest Close
- 18.09
- 12-Week Change
- 16.24%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Undecided 50.50%
- Signal Weeks
- 0 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- -4.00
- Market Dynamics
- 1.18
Over the latest 12 completed weeks ending 2026-07-24, CURE rose 16.24%, moving from 15.56 to 18.09. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -4.00 and has improved across the 12-week window. Market Dynamics is 1.18 on the latest week. Next-week expectancy is undecided at 50.50% based on similar historical setup states.